Cancer risk in multiple sclerosis: findings from British Columbia, Canada.
Posted on January 16, 2013 by
Good news but probably offset by use of immune-modulating/suppressive interventions (especially of cellular immunity) for MS. Do neurologists explain that to their patients? Another study to be done. Brain. 2012 Oct;135(Pt 10):2973-9. doi: 10.1093/brain/aws148. Epub 2012 Jun 21. Cancer risk in multiple sclerosis: findings from British Columbia, Canada. Kingwell E, Bajdik C, Phillips N, Zhu […]
Modifiable factors influencing relapses and disability in multiple sclerosis.
Posted on by
Mult Scler. 2010 Jul;16(7):773-85. doi: 10.1177/1352458510367721. Epub 2010 May 18. Modifiable factors influencing relapses and disability in multiple sclerosis. D’hooghe MB, Nagels G, Bissay V, De Keyser J. Source National Center For Multiple Sclerosis, Melsbroek, Belgium. marie.dhooghe@ms-centrum.be Abstract A growing body of literature indicates that the natural course of multiple sclerosis can be influenced by […]
Fingolimod treatment for multiple sclerosis patients What do we do with varicella?
Posted on by
Fingolimod treatment for multiple sclerosis patie… [Ann Neurol. 2011] – PubMed – NCBI. Ann Neurol. 2011 Oct;70(4):673-4; author reply 674. doi: 10.1002/ana.22605. Fingolimod treatment for multiple sclerosis patients What do we do with varicella? Winkelmann A, Loebermann M, Reisinger EC, Hartung HP, Zettl UK. Comment on Mechanisms of fingolimod’s efficacy and adverse effects in multiple […]
Melanoma occurring during treatment with fingo… [Arch Dermatol. 2011] – PubMed – NCBI
Posted on by
Arch Dermatol. 2011 Aug;147(8):991-2. doi: 10.1001/archdermatol.2011.212. Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report. Conzett KB, Kolm I, Jelcic I, Kamarachev J, Dummer R, Braun R, French LE, Linnebank M, Hofbauer GF. PMID: 21844470 [PubMed – indexed for MEDLINE] Publication Types, MeSH Terms, Substances LinkOut – more resources via Melanoma occurring […]
Delayed fingolimod-associated asystole. [Mult Scler. 2011] – PubMed – NCBI
Posted on by
Mult Scler. 2011 Nov;17(11):1387-9. doi: 10.1177/1352458511410344. Epub 2011 Jun 7. Delayed fingolimod-associated asystole. Espinosa PS, Berger JR. Source North Oaks Neurology, Hammond, LA, USA. ps.espinosa@gmail.com Abstract Oral fingolimod (Gilenya) is a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocytes from lymph nodes. Fingolimod reduces relapses and delays disability progression in patients with relapsing forms of […]